Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.475
-0.025 (-1.67%)
Apr 16, 2026, 1:16 PM EDT - Market open
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $62.3 million as of April 16, 2026. Its market cap has decreased by -76.74% in one year.
Market Cap
62.30M
Enterprise Value
49.97M
1-Year Change
-76.74%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $62.30M, a decrease of -95.33%. That is a compound annual growth rate of -42.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 63.36M | -30.50% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENSAR | 75.60M |
| Sensus Healthcare | 73.91M |
| Picard Medical | 71.19M |
| Xtant Medical Holdings | 70.03M |
| Baird Medical Investment Holdings | 65.74M |
| InspireMD | 65.02M |
| Spectral AI | 60.78M |
| PAVmed | 58.92M |